Vertaling van "tasigna is already available " (Nederlands → Frans) :

Tasigna is already available as a first line treatment for Ph+ CML in the US.
Tasigna est déjà disponible contre cette maladie aux Etats-Unis.

Tasigna is already approved in the US and Switzerland, for the treatment of adult patients with newly diagnosed Ph+ CML in chronic phase.
Tasigna est déjà autorisé aux Etats- Unis et en Suisse pour le traitement des adultes chez lesquels une LMC à Ph+ en phase chronique a été dépistée précocement.

The Client SDK generates a new public/private key pair (if no valid pair is already available from previous
The Client SDK generates a new public/private key pair (if no valid pair is already available from

The recommendations made in this report are based on the available epidemiological data, the main observations that have been made with regard to the problem and an inventory of the actions already put in place in Belgium.
Les recommandations émises découlent des données épidémiologiques disponibles, des principaux constats établis par rapport au problème et d’un inventaire d’actions déjà mises en place en Belgique.

The Resident Assessment Instrument (RAI) 444 is originally developed to Only for breast cancer and colon cancer, the US has higher survival rates assess the care needs of the elderly in institutions, and has later been than Belgium (data shown in documentation sheet in Supplement S1). To extended with instruments for different care settings and subgroups. In be able to distinguish the effect of early screening from the actual care, Belgium a national pilot project (the BelRAI) is ongoing, but is not yet implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).
Belgium a national pilot project (the BelRAI) is ongoing, but is not yet be able to distinguish the effect of early screening from the actual care, implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).